Liabilities of Bionik Laboratories Corp. from 31 Dec 2010 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Bionik Laboratories Corp. quarterly Liabilities in USD history and change rate from 31 Dec 2010 to 31 Mar 2023.
  • Bionik Laboratories Corp. Liabilities for the quarter ending 31 Mar 2023 was $5,002,715, a 186% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Bionik Laboratories Corp. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $5,002,715 +$3,254,090 +186% 31 Mar 2023 10-K 21 Jun 2023 2023 FY
Q4 2022 $4,207,061 -$6,215,046 -60% 31 Dec 2022 10-Q 08 Feb 2023 2023 Q3
Q3 2022 $3,307,036 -$6,817,526 -67% 30 Sep 2022 10-Q 09 Nov 2022 2023 Q2
Q2 2022 $2,406,343 -$3,353,479 -58% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q1
Q1 2022 $1,748,625 -$3,756,430 -68% 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q4 2021 $10,422,107 +$2,896,031 +38% 31 Dec 2021 10-Q 09 Feb 2022 2022 Q3
Q3 2021 $10,124,562 30 Sep 2021 10-Q 10 Nov 2021 2022 Q2
Q2 2021 $5,759,822 30 Jun 2021 10-Q 12 Aug 2021 2022 Q1
Q1 2021 $5,505,055 +$305,410 +5.9% 31 Mar 2021 10-K 09 Jun 2022 2022 FY
Q4 2020 $7,526,076 31 Dec 2020 10-Q 11 Feb 2021 2020 Q3
Q1 2020 $5,199,645 +$1,929,782 +59% 31 Mar 2020 10-K 24 Jun 2021 2021 FY
Q2 2019 $4,655,893 30 Jun 2019 10-Q 12 Aug 2019 2019 Q1
Q1 2019 $3,269,863 31 Mar 2019 10-Q 12 Aug 2019 2019 Q1
Q1 2017 $4,818,250 +$3,981,355 +476% 31 Mar 2017 10-K 27 Jun 2018 2018 FY
Q4 2016 $5,001,677 -$1,258,750 -20% 31 Dec 2016 10-Q 14 Feb 2017 2017 Q3
Q3 2016 $5,391,130 -$3,384,145 -39% 30 Sep 2016 10-Q 14 Nov 2016 2017 Q2
Q2 2016 $7,412,036 -$4,840,033 -40% 30 Jun 2016 10-Q 15 Aug 2016 2017 Q1
Q1 2016 $836,895 +$295,162 +54% 31 Mar 2016 8-K 21 Dec 2017
Q4 2015 $6,260,427 +$5,796,017 +1248% 31 Dec 2015 10-KT 30 Jun 2016 2016 FY
Q3 2015 $8,775,275 +$8,750,816 +35777% 30 Sep 2015 10-Q 17 Mar 2016 2015 Q3
Q2 2015 $12,252,069 30 Jun 2015 10-Q 17 Mar 2016 2015 Q2
Q1 2015 $541,733 -$748,914 -58% 31 Mar 2015 8-K 21 Dec 2017
Q4 2014 $464,410 +$450,178 +3163% 31 Dec 2014 10-KT 30 Jun 2016 2016 FY
Q3 2014 $24,459 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q1 2014 $1,290,647 31 Mar 2014 10-KT 27 May 2015 2014 FY
Q4 2013 $14,232 +$12,582 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q4 2012 $1,650* -$4,682 31 Dec 2012 10-K 06 Mar 2013 2012 FY
Q2 2012 $6,515* 30 Jun 2012 10-Q 07 Aug 2012 2012 FY
Q1 2012 $6,425* 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 $6,332* +$332 31 Dec 2011 10-K 06 Mar 2013 2012 FY
Q3 2011 $6,090* 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
Q4 2010 $6,000* 31 Dec 2010 10-K 11 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.